Skip to main content
. 2017 Mar 10;8(19):31169–31179. doi: 10.18632/oncotarget.16099

Table 4. Multivariable analysis of selected demographic variables and ETS or DpR categorized by cutoff values.

    Progression-free Survival Overall Survival
    Adjusted for Covariates Adjusted for Covariates
    HR 95% CI P HR 95% CI P
Age < 65 Ref Ref
≥ 65 0.816 0.433 to 1.540 0.531 0.945 0.441 to 2.026 0.885
ECOG performance status 0 Ref Ref
≥ 1 1.689 0.928 to 3.075 0.086 2.404 1.145 to 5.049 0.021
HER2 overexpression by IHC 2+ Ref Ref
3+ 0.521 0.274 to 0.993 0.048 0.949 0.429 to 2.100 0.897
ETS < 30% Ref Ref
≥ 30% 0.665 0.371 to 1.193 0.171 0.687 0.332 to 1.423 0.312
Age < 30% Ref Ref
≥ 65 0.896 0.488 to 1.626 0.720 1.025 0.488 to 2.147 0.950
ECOG performance status 0 Ref Ref
≥ 1 1.582 0.861 to 2.915 0.141 2.213 1.045 to 4.675 0.038
HER2 overexpression by IHC 2+ Ref Ref
3+ 0.587 0.298 to 1.827 0.122 1.224 0.526 to 2.848 0.639
DpR < 45% Ref Ref
≥ 45% 0.609 0.335 to 1.107 0.104 0.441 0.204 to 0.955 0.038

Abbreviations: HR, hazard ratio; CI, confidence interval; Ref, Reference; ECOG, Eastern Cooperative Oncology Group; HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry; ETS, early tumor shrinkage; DpR, depth of response